Tripterygium Glycoside Tablets Combined With Conventional Synthetic Disease-Modifying Antirheumatic Drugs for Treating Rheumatoid Arthritis: Protocol for a Prospective, Multicenter, Open-Label Randomized Controlled Trial
Tripterygium Glycoside Tablets Combined With Conventional Synthetic Disease-Modifying Antirheumatic Drugs for Treating Rheumatoid Arthritis: Protocol for a Prospective, Multicenter, Open-Label Randomized Controlled Trial
Liu Lv
1
* , MM ;
Tuoran Wang
2
* , MM ;
Jing Lv
3
, MM ;
Chunping Liu
1
, MM ;
Luming Zhao
1
, MM ;
Yu Zhou
2
, MM
1
Department of Rheumatology, Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Beijing, China
2
Acupuncture and Moxibustion Hospital, Institute of Acupuncture and Moxibustion, China Academy of Chinese Medical Sciences, Beijing, China
3
Department of Rheumatology, Wuhan Hospital of Traditional Chinese Medicine, Wuhan, China
*these authors contributed equally
Corresponding Author:
-
Yu Zhou, MM
-
Acupuncture and Moxibustion Hospital, Institute of Acupuncture and Moxibustion
-
China Academy of Chinese Medical Sciences
-
No. 16 Nanxiaojie, Dongzhimennei, Dongcheng District
-
Beijing
-
China
-
Phone:
86 13520302630
-
Email: 13520302630@163.com